Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 5
2022 9
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ahmed hanaa[Author] (119 results)?
Autoimmune manifestations in STAG2-mutated myeloid neoplasms.
Katamesh B, Nanaa A, He R, Viswanatha D, Nguyen P, Greipp P, Foran J, Begna K, Gangat N, Patnaik M, Tefferi A, Litzow M, Mangaonkar A, Shah MV, Badar T, Alkhateeb HB, Al-Kali A. Katamesh B, et al. Among authors: nanaa a. Ann Hematol. 2022 Dec;101(12):2785-2787. doi: 10.1007/s00277-022-04995-5. Epub 2022 Oct 3. Ann Hematol. 2022. PMID: 36184685 No abstract available.
Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasms.
Badar T, Nanaa A, Foran JM, Viswanatha D, Al-Kali A, Lasho T, Finke C, Alkhateeb HB, He R, Gangat N, Shah M, Tefferi A, Mangaonkar AA, Litzow MR, Ongie LJ, Chlon T, Ferrer A, Patnaik MM. Badar T, et al. Among authors: nanaa a. Haematologica. 2023 Nov 1;108(11):3033-3043. doi: 10.3324/haematol.2023.282867. Haematologica. 2023. PMID: 37199125 Free PMC article. Review.
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
Al-Kali A, Nanaa A, Viswanatha D, He R, Nguyen P, Jevremovic D, Foran JM, Yi CA, Greipp PT, Gangat N, Patnaik M, Tefferi A, Litzow MR, Mangaonkar AA, Shah MV, Badar T, Alkhateeb HB. Al-Kali A, et al. Among authors: nanaa a. Blood Cancer J. 2023 Apr 10;13(1):49. doi: 10.1038/s41408-023-00818-6. Blood Cancer J. 2023. PMID: 37032414 Free PMC article. No abstract available.
Comparison between GATA2 and DDX41-mutated myeloid neoplasms.
Nanaa A, He R, Viswanatha D, Nguyen P, Jevremovic D, Foran JM, Yi CA, Greipp PT, Gangat N, Patnaik M, Tefferi A, Litzow MR, Mangaonkar AA, Shah MV, Badar T, Alkhateeb HB, Al-Kali A. Nanaa A, et al. Leuk Res. 2022 Oct;121:106931. doi: 10.1016/j.leukres.2022.106931. Epub 2022 Aug 23. Leuk Res. 2022. PMID: 36037623 No abstract available.
Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms.
Katamesh B, Nanaa A, He R, Viswanatha D, Nguyen P, Greipp P, Foran J, Begna K, Gangat N, Patnaik M, Tefferi A, Litzow M, Mangaonkar A, Shah MV, Badar T, Alkhateeb HB, Al-Kali A. Katamesh B, et al. Among authors: nanaa a. Ann Hematol. 2023 Jan;102(1):211-212. doi: 10.1007/s00277-022-05016-1. Epub 2022 Nov 4. Ann Hematol. 2023. PMID: 36331566 No abstract available.
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.
Badar T, Vanegas YAM, Nanaa A, Foran JM, Al-Kali A, Mangaonkar A, Murthy H, Alkhateeb HB, Viswanatha D, He R, Shah M, Yi CA, Litzow MR, Gangat N, Tefferi A, Patnaik MM. Badar T, et al. Among authors: nanaa a. Blood Cancer J. 2023 Sep 21;13(1):149. doi: 10.1038/s41408-023-00922-7. Blood Cancer J. 2023. PMID: 37735430 Free PMC article.
Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms.
Shah MV, Mangaonkar AA, Begna KH, Alkhateeb HB, Greipp P, Nanaa A, Elliott MA, Hogan WJ, Litzow MR, McCullough K, Tefferi A, Gangat N, Patnaik MM, Al-Kali A, He R, Chen D. Shah MV, et al. Among authors: nanaa a. Blood Cancer J. 2022 Jul 8;12(7):106. doi: 10.1038/s41408-022-00703-8. Blood Cancer J. 2022. PMID: 35803921 Free PMC article.
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Badar T, Nanaa A, Atallah E, Shallis RM, Guilherme SCC, Goldberg AD, Saliba AN, Patel A, Bewersdorf JP, DuVall AS, Bradshaw D, Abaza Y, Murthy GSG, Palmisiano N, Zeidan AM, Kota V, Litzow MR. Badar T, et al. Among authors: nanaa a. Blood Cancer J. 2024 Feb 20;14(1):32. doi: 10.1038/s41408-024-01000-2. Blood Cancer J. 2024. PMID: 38378617 Free PMC article.
21 results